TL;DR
This study investigates the prevalence of mutations in the TIGR/MYOC gene, a known contributor to primary open-angle glaucoma (POAG), and their association with age of disease onset. The findings reveal a significant age-dependent pattern, with mutations being much more common in families with juvenile-onset or mixed-onset POAG compared to those with only adult-onset disease, suggesting a potential genetic marker for identifying individuals at higher risk.
What Problem Does This Paper Address?
Primary open-angle glaucoma (POAG) is a leading cause of blindness characterized by optic nerve damage and visual field loss, often associated with elevated intraocular pressure. POAG can manifest at different ages, broadly categorized into juvenile-onset (before 35 years) and adult-onset (35 years and older). While the GLC1A locus, specifically the TIGR/MYOC gene, was identified as a cause of familial POAG, its mutation prevalence across different age groups and its potential as a predictive marker remained unclear. This paper aims to systematically screen for TIGR/MYOC mutations in a cohort of POAG patients and their families, and to analyze the frequency of these mutations in relation to the age of disease onset, seeking to understand if genetic predisposition varies with age and if this can inform risk assessment.
Methods
The researchers screened the TIGR/MYOC gene (coding sequences and splice sites) in 74 unrelated POAG probands and their relatives. This involved:
- DNA Sequencing: Standard Sanger sequencing was used to identify mutations in the TIGR/MYOC gene.
- Allele-Specific Oligonucleotide Hybridization (ASO): This technique was employed to screen family members and normal controls for specific known sequence variants.
- Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP): Used for specific mutations (e.g., Thr377Met) to detect the presence of the variant allele.
- Triton Solubility Assay: A functional assay to assess whether identified mutations lead to insoluble protein, a characteristic of pathogenic TIGR/MYOC mutations. This involved transfecting cells with constructs encoding normal or mutant proteins and analyzing protein solubility via immunoblot.
- Founder Effect Analysis: Short tandem repeat (STR) polymorphisms were used to investigate potential shared ancestry in families with the same mutation.
Datasets
The study utilized data from:
- 74 unrelated individuals with primary open-angle glaucoma: These individuals formed the primary cohort for mutation screening.
- 60 normal controls: Used to assess the prevalence of identified variants in the general population.
- Family members of the POAG probands: Information on affected and unaffected relatives was collected to assess cosegregation of mutations with the disease.
No new benchmark datasets were introduced; the focus was on analyzing existing patient and control populations.
Key Insights and Ideas
- Age is a critical factor in TIGR/MYOC mutation prevalence: The most striking finding is the stark difference in mutation frequency between age-defined groups.
- Juvenile and mixed-onset POAG are genetically enriched: Families with juvenile-onset POAG and those with a mix of juvenile and adult-onset cases showed a significantly higher proportion of TIGR/MYOC mutations.
- Adult-onset POAG has low TIGR/MYOC mutation rates: Families with only adult-onset POAG had virtually no detectable mutations in this gene, suggesting other genetic or environmental factors are more dominant in this subset.
- Potential for targeted genetic screening: The age-dependent prevalence suggests that individuals with a family history of juvenile POAG might be a more suitable target population for TIGR/MYOC mutation testing, even if they themselves present with adult-onset disease.
- Novel mutations identified: The study identified several new sequence variants, including Asn57Asp, Arg272Gly, and Ile499Ser, contributing to the growing list of TIGR/MYOC mutations associated with POAG.
- Functional evidence for pathogenicity: The Triton solubility assay provided functional support for classifying nine of the identified variants as likely pathogenic.
Key Results
- Mutation Detection: 13 nonsynonymous sequence variants were detected in 25 of the 74 screened families. Nine of these were classified as likely pathogenic mutations.
- Age-Dependent Mutation Frequency:
- Families: 33% of juvenile POAG families, 31% of mixed-onset POAG families, and 0% of adult-onset POAG families harbored mutations.
- Probands: 36% of juvenile POAG probands and 4% of adult-onset POAG probands carried mutations.
- Novel Mutations: Three novel nonsynonymous sequence variants (Asn57Asp, Arg272Gly, Ile499Ser) were identified.
- Functional Assays: Nine identified variants (Gly252Arg, Arg272Gly, Glu323Lys, Gln368STOP, Pro370Leu, Thr377Met, Val426Phe, Ile477Asn, Ile499Ser) produced insoluble protein in the Triton solubility assay, consistent with pathogenic mutations.
- Control Population: Most identified pathogenic variants were absent in normal controls, with some exceptions for variants not classified as causative.
Limitations and Future Work
- Ascertainment Bias: The study acknowledges that the screened population may not be a perfectly unbiased representation of all POAG cases, which could affect overall mutation frequency estimates.
- Limited Power for Rare Variants: Some variants (e.g., Asn57Asp) were not found in controls and had limited family data, making definitive classification challenging.
- Need for Larger Studies: The authors emphasize the need for larger, prospective studies with different ascertainment bases to refine mutation prevalence estimates and validate the predictive value of age-related family history.
- Understanding Gln368STOP Variability: The significant variability in expressivity and age of onset for the Gln368STOP mutation warrants further investigation to understand its predictive value for glaucoma risk versus initial intraocular pressure elevation.
- Functional Domain Prediction: While the study predicts a charge-sensitive domain and potential phosphorylation sites in exon 3 of TIGR/MYOC, further experimental work is needed to confirm these hypotheses.
The paper concludes that while TIGR/MYOC mutations are more prevalent in younger POAG patients, the presence of juvenile POAG relatives might indicate an increased risk for adult-onset POAG patients, suggesting a potential avenue for more targeted genetic screening.
Summary updated